AI meets Biophysics for Drug Discovery

Cyclica is a Toronto-based, globally recognized biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process.

Cyclica provides the pharmaceutical industry Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights. Taken together Ligand Design and Ligand Express empower scientists with an integrated, holistic, and end-to-end enabling platform focused on polypharmacology that enhances how scientists design, screen, and personalize medicines for patients while minimizing off-target side effects.

By doing more with artificial intelligence, Cyclica aims to revolutionize a system troubled with attrition and costly failures, accelerate the drug discovery process, and develop medicines with greater precision.


See what the market is saying about us: